SCHEMBL6423571

SCHEMBL6423571

Cc1c(C(C(=O)O)C2CCC2)c2c(F)c(O)ccc2n1C(=O)c1cccc(F)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP2 O75604 1/20 0.39
PIK3CD O00329 1/20 0.39
TDP1 Q9NUW8 2/20 0.39
KDM4E B2RXH2 2/20 0.39
SMN1; SMN2 Q16637 1/20 0.38
HTT P42858 1/20 0.38
ALDH1A1 P00352 3/20 0.37
KMT2A Q03164 2/20 0.37
MEN1 O00255 1/20 0.37
EPHX2 P34913 1/20 0.37
LMNA P02545 1/20 0.36
AKR1C3 P42330 1/20 0.36
AKR1C2 P52895 1/20 0.36
GRM5 P41594 1/20 0.36
HSD11B1 P28845 1/20 0.36
CHRNB2 P17787 1/20 0.35
SLC6A2 P23975 1/20 0.35
CHRNB4 P30926 1/20 0.35
CHRNA3 P32297 1/20 0.35
CHRNA4 P43681 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6426581 0.98 TDP1 (0.41) USP2PIK3CDTDP1KDM4ESMN1; SMN2
SCHEMBL6424245 0.91 ALDH1A1 (0.37) KDM4EALDH1A1KMT2AMEN1GRM5
SCHEMBL6425599 0.89 L3MBTL1 (0.39) KDM4EALDH1A1KMT2AMEN1HSD11B1
SCHEMBL6424656 0.88 USP2 (0.38) USP2PIK3CDTDP1KDM4ESMN1; SMN2
SCHEMBL6424426 0.88 KMT2A (0.36) HTTALDH1A1KMT2AMEN1LMNA
SCHEMBL6424129 0.86 TDP1 (0.40) USP2PIK3CDTDP1KDM4ESMN1; SMN2
SCHEMBL6426891 0.86 HSD11B1 (0.37) ALDH1A1LMNAAKR1C3AKR1C2HSD11B1
SCHEMBL6424476 0.86 KMT2A (0.36) KMT2AMEN1AKR1C3AKR1C2GRM5
SCHEMBL6426945 0.85 PDE2A (0.35) AKR1C3AKR1C2HSD11B1
SCHEMBL6425922 0.85 AKR1C3 (0.40) KDM4EKMT2AMEN1LMNAAKR1C3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050234244-A1 Synthesis of COX-2 and FAAH inhibitors IRONWOOD PHARMACEUTICALS, INC. 2005-10-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050234244-A1 Synthesis of COX-2 and FAAH inhibitors FAAH2, FAAH, PTGES2 USP2 156/4885PIK3CD 2741/4885TDP1 3450/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.